Revisions for Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcinoma | Registro Público Cubano de Ensayos Clínicos

Published clinical_trials Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcinoma has 4 revisions.

Revision		Status
Saved 01/10/2026 - 10:52am by lazara		current revision (published)
Saved 01/10/2026 - 10:51am by lazara		archived
Saved 01/10/2026 - 10:18am by lazara		archived
Saved 24/08/2026 - 2:35pm by Gladys Thanks for the posibility to share this clinical trial in the www.		archived

Registered Trials

Registration process

About the RPCEC

Useful resources